ForGrowth NAP B.V.
SEC CIK 2005407 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | 10% | 10.66M | — | $5.88M | 3 | 2024-11-15 | 2024-12-30 |
Most active insiders at NAMS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davidson Michael H. | CEO, Dir | $226.5K | $25.33M |
| 2 | Kooij Louise Frederika | CAO | — | $16.75M |
| 3 | Kastelein Johannes Jacob Pieter | CSO, Dir | — | $14.26M |
| 4 | Somaiya Mayur Ian | CFO | — | $3.43M |
| 5 | LANGE LOUIS G | Dir | — | $2.19M |
| 6 | Smither John W | Dir | — | $40.5K |
| 7 | Gunning Robert William | VP, Ctrl | — | — |
| 8 | van der Kamp Hilde Johanna | Dir | — | — |
| 9 | McKenna Mark C. | Dir | — | — |
| 10 | Gulfo Adele M. | Dir | — | — |
ForGrowth NAP B.V. made no open-market trades at NAMS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2025-01-02 | 2024-12-30 | NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% | S - Sale | $25.54 | -29.8K | 10.66M | -0.3% | -$762.3K |
| MTI | 2024-12-20 | 2024-12-18+ | NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% | S - Sale | $25.87 | -157.2K | 10.91M | -1% | -$4.07M |
| MTI | 2024-11-19 | 2024-11-15+ | NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% | S - Sale | $25.07 | -41.8K | 11.78M | -0.4% | -$1.05M |
Purchase Sale Sale after option exercise All abbreviations